基于药,对接和分子动力学的PqsR抑制剂虚拟查的多维标准
Haichuan Xiao1, Jiahao Li1, Dongdong Yang1
1College of Pharmacy, Jinan University, Guangzhou 510632, China.
International journal of molecular sciences
|February 10, 2024
概括
这项研究开发了一种新的多维查模型,以发现更好的定数感应抑制剂 (QSI),以PqsR为向Pseudomonas aeruginosa. 该模型增强了有效的PqsR抑制剂的识别,以对抗抗生素耐药性.
科学领域:
- 微生物学 微生物学
- 计算化学计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 由于抗生素耐药性很高,Pseudomonas aeruginosa构成了重大威胁.
- 质量感应抑制剂 (QSI) 提供了一种通过破坏细菌通信来克服抵抗的策略.
- PqsR是Pseudomonas aeruginosa定数感应中的关键调节器,但PqsR抑制剂研究缺乏化学多样性和有效查.
研究的目的:
- 开发一个多维查模型用于PqsR抑制剂.
- 整合基于连接体和受体的方法,以提高抑制剂的发现.
- 改进新型PqsR抑制剂的识别和优化.
主要方法:
- 从已知的PqsR抑制剂构建了一个药模型.
- 利用分子对接和动力学模拟来分析PqsR-抑制剂相互作用.
- 使用PqsR抑制剂测试组验证了模型的有效性.
主要成果:
- 确定了有效的PqsR抑制剂的关键结构特征:两个芳香环,一个键受体和两个疏水组.
- 确定了与氨基酸残留TYR_258,ILE_236,LEU_208和GLN_194.4的关键相互作用.
- 确定的最佳对接得分 (< -8 kcal/mol) 和结合的自由能量 (< -40 kcal/mol) 值.
- 与单一特征查方法相比,证明了更高的准确性.
结论:
- 开发的多维查模型准确地预测了PqsR抑制剂的活性.
- 该模型为发现和优化新型PqsR抑制剂提供了一个强大的框架.
- 这些发现有助于打击Pseudomonas aeruginosa感染中的抗生素耐药性.
相关概念视频
Structure-Activity Relationships and Drug Design
721
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
721
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Quantitative Aspects of Drug-Receptor Interaction
982
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
982


